Erratum: FSD-C10: A more promising novel ROCK inhibitor than Fasudil for treatment of CNS autoimmunity (Bioscience Reports DOI: 10.1042/BSR20150032);FSD-C10: A more promising novel ROCK inhibitor than Fasudil for treatment of CNS autoimmunity

Bioscience Reports

Volumn 35, Issue 5, 2015, Pages

  Xin, Yan Le ^a   Yu, Jie Zhong ^a   Yang, Xin Wang ^a   Liu, Chun Yun ^a   Li, Yan Hua ^a   Feng, Ling ^a   Chai, Zhi ^b   Yang, Wan Fang ^b   Wang, Qing ^b   Jiang, Wei Jia ^b   Zhang, Guang Xian ^c   Xiao, Bao Guo ^d   Ma, Cun Gen ^a,b  

^a SHANXI DATONG UNIVERSITY   (China)

^b SHANXI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d FUDAN UNIVERSITY   (China)

Author keywords

Fasudil; FSD C10; Rho kinase; Rho kinase inhibitor

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; FASUDIL; FSD C 10; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NEUROTROPHIN 3; RHO KINASE INHIBITOR; UNCLASSIFIED DRUG; 1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; ISOQUINOLINE DERIVATIVE; NEUROPROTECTIVE AGENT; PROTEIN KINASE INHIBITOR; RHO KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MEDIATED CYTOTOXICITY; CELL VIABILITY; COMPARATIVE EFFECTIVENESS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENDRITE; DRUG SAFETY; DRUG STRUCTURE; DRUG SYNTHESIS; EMBRYO; ENZYME INHIBITION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; MACROPHAGE; MICROGLIA; MORTALITY; MOUSE; MULTIPLE SCLEROSIS; NERVE CELL NECROSIS; NERVE FIBER GROWTH; NONHUMAN; PROTEIN SYNTHESIS; VASODILATATION; ANIMAL; AUTOIMMUNITY; C57BL MOUSE; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; ENCEPHALOMYELITIS; ENZYMOLOGY; METABOLISM; MOLECULAR MODEL; NERVE CELL;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ANIMALS; AUTOIMMUNITY; CELL SURVIVAL; CELLS, CULTURED; ENCEPHALOMYELITIS; FEMALE; ISOQUINOLINES; MICE, INBRED C57BL; MODELS, MOLECULAR; NEURONS; NEUROPROTECTIVE AGENTS; PROTEIN KINASE INHIBITORS; RHO-ASSOCIATED KINASES; VASODILATION;

EID: 84942422083     PISSN: 01448463     EISSN: 15734935     Source Type: Journal    
DOI: 10.1042/BSR-2015-0032_EOC     Document Type: Erratum

References (49)

1. Guilluy, C., Garcia-Mata, R. and Burridge, K. (2011) Rho protein crosstalk: another social network? Trends Cell Biol. 21, 718-726
2. Li, Q., Huang, X.J., He, W., Ding, J., Jia, J.T., Fu, G., Wang, H.X. and Guo, L.J. (2009) Injury of neuroprotective potential of fasudil mesylate in brain is chemia-reperfusion rats. Cell Mol. Neurobiol. 29, 169-180
3. Sun, X., Minohara, M., Kikuchi, H., Ishizu, T., Tanaka, M., Piao, H., Osoegawa, M., Ohyagi, Y., Shimokawa, H. and Kira, J. (2006) The selective Rhokinase inhibitor Fasudil is protective and therapeutic in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 180, 126-134
4. Huang, X.N., Fu, J. and Wang, W.Z. (2011) The effects of fasudil on the permeability of the rat blood-brain barrier and blood-spinal cord barrier following experimental autoimmune encephalomyelitis. J. Neuroimmunol. 239, 61-67
5. Hou, S.W., Liu, C.Y., Li, Y.H., Yu, J.Z., Feng, L., Liu, Y.T., Guo, M.F., Xie, Y., Meng, J., Zhang, H.F. et al. (2012) Fasudil ameliorates disease progression in experimental autoimmune encephalomyelitis, acting possibly through antiinflammatory effect. CNS Neurosci. Ther. 18, 909-917
6. Liu, C.Y., Li, Y.H., Yu, J.Z., Feng, L., Hou, S.W., Liu, Y., Guo, M., Xie, Y., Meng, J., Zhang, H. et al. (2013) Targeting the shift from M1 to M2 macrophages in experimental autoimmune encephalomyelitis mice treated with Fasudil. PLoS One 8, e54841
7. Takata, M., Tanaka, H., Kimura, M., Nagahara, Y., Tanaka, K., Kawasaki, K., Seto, M., Tsuruma, K., Shimazawa, M. and Hara, H. (2013) Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis. Br. J. Pharmacol. 170, 341-351
8. Song, Y., Chen, X., Wang, L.Y., Gao, W. and Zhu, M.J. (2013) Rho kinase inhibitor fasudil protects against ß-amyloid-induced hippocampal neurodegeneration in rats. CNS Neurosci. Ther. 19, 603-610
9. Tönges, L., Frank, T., Tatenhorst, L., Saal, K.A., Koch, J.C., Szego, É.M., Bähr, M., Weishaupt, J.H. and Lingor, P. (2012) Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's disease. Brain 135, 3355-3370
10. Rodriguez-Perez, A.I., Dominguez-Meijide, A., Lanciego, J.L., Guerra, M.J. and Labandeira-Garcia, J.L. (2013) Inhibition of Rho kinase mediates theneuroprotective effects of estrogen in the MPTP model of Parkinson's disease. Neurobiol. Dis. 58, 209-219
11. Mueller, B.K., Mack, H. and Teusch, N. (2005) Rho kinase, a promising drug target for neurological disorders. Nat. Rev. Drug. Discov. 4, 387-398
12. Ding, J., Yu, J.Z., Li, Q.Y., Wang, X., Lu, C.Z. and Xiao, B.G. (2009) Rho kinase inhibitor Fasudil Induces neuropro tection and neurogenesis partially through as trocyte-derived G-CSF. Brain Behav. Immun. 23, 1083-1088
13. Ding, J., Li, Q.Y., Yu, J.Z., Wang, X., Sun, C.H., Lu, C.Z. and Xiao, B.G. (2010) Fasudil, a Rho kinase inhibitor, drives mobilization of adult neural stem cells after hypoxia/reoxygenation injury in mice. Mol. Cell. Neurosci. 43, 201-208
14. Shimokawa, H., Yamashita, K., Kotani, Y., Nakajima, Y., Shimazawa, M., Yoshimura, S., Nakashima, S., Iwama, T. and Hara, H. (2007) Fasudil, a Rho kinase (ROCK) inhibitor, protects against ischemic neuronal damage in vitro and in vivo by acting directly on neurons. Brain Res. 1154, 215-224
15. Chao, M.V. (1992) Neurotrophin receptors: a window into neuronal differentiation. Neuron 9, 583-593
16. Nilsen, J. and Brinton, R.D. (2002) Impact of progestinson estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate. Endocrinology 143, 205-212
17. Takami, A., Iwakubo, M., Okada, Y., Kawata, T., Odai, H., Takahashi, N., Shindo, K., Kimura, K., Tagami, Y., Miyake, M. et al. (2004) Design and synthesis of Rho kinase inhibitors. Bioorg. Med. Chem. 12, 2115-2137
18. Lingor, P., Teusch, N., Schwarz, K., Muller, R., Mack, H., Bahr, M. and Mueller, B.K. (2007) Inhibition of Rho kinase (ROCK) increases neurite outgrowth on chondroitin sulphate proteoglycan in vitro and axonal regeneration in the adult optic nerve in vivo. J. Neurochem. 103, 181-189
19. Lingor, P., Tonges, L., Pieper, N., Bermel, C., Barski, E., Planchamp, V. and Bahr, M. (2008) ROCK inhibition and CNTF interact on intrinsic signalling pathways and differentially regulate survival and regeneration in retinal ganglion cells. Brain 131, 250-263
20. Li, Y.H., Yu, J.Z., Liu, C.Y., Zhang, H., Zhang, H.F., Yang, W.F., Li, J.L., Feng, Q.J., Feng, L., Zhang, G.X. et al. (2014) Intranasal delivery of FSD-C10, a novel Rho kinase inhibitor, exhibts therapeutic potential in experimental autoimmune encephalomyelitis. Immunology 143, 219-229
21. Takaku, S., Yanagisawa, H., Watabe, K., Horie, H., Kadoya, T., Sakumi, K., Nakabeppu, Y., Poirier, F. and Sango, K. (2013) GDNF promotes neurite outgrowth and upregulates galectin-1 through the RET/PI3K signaling in cultured adult rat dorsal root ganglion neurons. Neurochem. Int. 62, 330-339
22. Chao, M.V. (2003) Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat. Rev. Neurosci. 4, 299-309
23. Hammarberg, H., Lidman, O., Lundberg, C., Eltayeb, S.Y., Gielen, A.W., Muhallab, S., Svenningsson, A., Lindå, H., Meide, P.H., Cullheim, S. et al. (2000) Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. J. Neurosci. 20, 5283-5291
24. Hohlfeld, R., Kerschensteiner, M., Stadelmann, C., Lassmann, H. and Wekerle, H. (2000) The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis. J. Neuroimmunol. 107, 161-166
25. McTigue, D.M., Horner, P.J., Stokes, B.T. and Gage, F.H. (1998) Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. J. Neurosci. 18, 5354-5365
26. Korte, M., Carroll, P., Wolf, E., Brem, G., Thoenen, H. and Bonhoeffer, T. (1995) Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc. Natl. Acad. Sci. U.S.A. 92, 8856-8860
27. Kernie, S.G., Liebl, D.J. and Parada, L.F. (2000) BDNF regulates eating behavior and locomotor activity in mice. EMBO J. 19, 1290-1300
28. Lyons, W.E., Mamounas, L.A., Ricaurte, G.A., Coppola, V., Reid, S.W., Bora, S.H., Wihler, C., Koliatsos, V.E. and Tessarollo, L. (1999) Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc. Natl. Acad. Sci. U.S.A. 96, 15239-15244
29. Rios, M., Fan, G.P., Fekete, C., Kelly, J., Bates, B., Kuehn, R. and Jaenisch, R. (2001) Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol. Endocrinol. 15, 1748-1757
30. Zhou, X., He, X.H., He, B., Zhu, H.W., Zheng, C.B., Xu, J., Jiang, L., Gu, L.Q., Zhu, J.K., Zhu, Q.T. and Liu, X.L. (2013) Etifoxine promotes glial-derived neurotrophic factorinduced neurite outgrowth in PC12 cells. Mol. Med. Rep. 8, 75-80
31. Aharoni, R., Eilam, R., Domev, H., Labunskay, G., Sela, M. and Arnon, R. (2005) The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice. Proc. Natl. Acad. Sci. U.S.A. 102, 19045-19050
32. Kalcheim, C., Carmeli, C. and Rosenthal, A. (1992) Neurotrophin 3 is a mitogen for cultured neural crest cells. Proc. Natl. Acad. Sci. U.S.A. 89, 1661-1665
33. Barres, B.A., Raff, M.C., Gaese, F., Bartke, I., Dechant, G. and Barde, Y.A. (1994) A crucial role for neurotrophin-3 in oligodendrocyte development. Nature 367, 371-375
34. Pluchino, S., Muzio, L., Imitola, J., Deleidi, M., Alfaro-Cervello, C., Salani, G., Porcheri, C., Brambilla, E., Cavasinni, F., Bergamaschi, A. et al. (2008) Persistent inflammation alters the function of the endogenous brain stem cell compartment. Brain 131, 2564-2578
35. Yang, J., Yan, Y., Xia, Y., Kang, T., Li, X., Ciric, B., Xu, H., Rostami, A. and Zhang, G.X. (2014) Neurotrophin 3 transduction augments remyelinating and immunomodulatory capacity of neural stem cells. Mol. Ther. 22, 440-450
36. Sekimoto, M., Tsuji, T., Matsuzaki, J., Chamoto, K., Koda, T., Nemoto, K., Degawa, M., Nishimura, S. and Nishimura, T. (2003) Functional expression of the TrkC gene, encoding a high affinity receptor for NT-3, in antigen-specific T helper type 2 (Th2) cells. Immunol. Lett. 88, 221-226
37. Blits, B., Oudega, M., Boer, G.J., Bartlett Bunge, M. and Verhaagen, J. (2003) Adenoassociated viral vector-mediated neurotrophin gene transfer in the injured adult rat spinal cord improves hind-limb function. Neuroscience 118, 271-281
38. Park, J.W., Kang, Y.D., Kim, J.S., Lee, J.H. and Kim, H.W. (2014) 3D microenvironment of collagen hydrogel enhances the release of neurotrophic factors from human umbilical cord blood cells and stimulates the neurite outgrowth of human neural precursor cells. Biochem. Biophysi. Res. Commun. 447, 400-406
39. Montefusco, S., Esposito, R., D'Andrea, L., Monti, M.C., Dunne, C., Dolan, B., Tosco, A., Marzullo, L. and Clyne, M. (2013) Copper promotes TFF1-mediated Helicobacter pylori colonization. PLoS One 8, e79455
40. Kubo, T., Hata, K., Yamaguchi, A. and Yamashita, T. (2007) Rho-ROCK inhibitors as emerging strategies to promote nerve regeneration. Curr. Pharm. Des. 13, 2493-2499
41. Wang, X., Chun, S.J., Treloar, H., Vartanian, T., Greer, C.A. and Strittmatter, S.M. (2002) Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact. J. Neurosci. 22, 5505-5515
42. Schmitz, T. and Chew, L.J. (2008) Cytokines and myelination in the central nervous system. Scientific World Journal 8, 1119-1147
43. Ming, X.F., Viswambharan, H., Barandier, C., Ruffieux, J., Kaibuchi, K., Rusconi, S. and Yang, Z.H. (2002) Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial Cells. Mol. Cell. Biol. 22, 8467-8477
44. Bussemaker, E., Pistrosch, F., Forster, S., Herbrig, K., Gross, P., Passauer, J. and Brandes, R.P. (2007) Rho kinase contributes to basal vascular tone in humans: role of endothelium derived nitric oxide. Am. J. Physiol. Heart Circ. Physiol. 293, H541-H547
45. Masumoto, A., Hirooka, Y., Shimokawa, H., Hironaga, K., Setoguchi, S. and Takeshita, A. (2001) Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans. Hypertension 38, 1307-1310
46. Loirancl, G. and Pacaud, P. (2010) The of Pho protein in hytension. Nat. Rev. Cardiol. 7, 637-647
47. Wang, Y., Zheng, X.R., Riddick, N., Bryden, M., Baur, W., Zhang, X. and Surks, H.K. (2009) ROCK Isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells. Circ. Res. 104, 531-540
48. Noma, K., Rikitake, Y., Oyama, N., Yan, G.J., Alcaide, P., Liu, P.Y., Wang, H.W., Ahl, D., Sawada, N., Okamoto, R. et al. (2008) ROCK1 mediates leukocyte recruitment and neointima formation following vascular injury. J. Clin. Invest. 18, 1632-1644
49. Zhang, Y.M., Bo, J., Taffet, G.E., Chang, J., Shi, J.J., Reddy, A.K., Michael, L.H., Schneider, M.D., Entman, M.L., Schwartz, R.J. and Wei, L. (2006) Targeted deletion of ROCK1 protects the heart against pressure overload by inhibiting reactive fibrosis. FASEB J. 20, 916-925